Pimecrolimus for the treatment of inflammatory skin disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.3, 2004-03, pp. : 643-655

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pimecrolimus - advancing towards long-term management of inflammatory skin diseases

Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

IL-20: a new target for the treatment of inflammatory skin disease

By Rich Benjamin E

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 165-174

Informa Healthcare

Access to resources Recommend Favorite

Topical tacrolimus for the treatment of inflammatory skin diseases

By Assmann Till Homey Bernhard Ruzicka Thomas

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1167-1175

Informa Healthcare

Access to resources Recommend Favorite

Ascomycins: promising agents for the treatment of inflammatory skin diseases

By Paul C. Graeber M. Stuetz A.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 69-77

Informa Healthcare

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite